Sign In
Buy IQV
$182.05
+1.41 (+0.781%)
At Close: Jun 03, 2026
Lone Pine Capital Exits Salesforce, Union Pacific
05:18pm, Thursday, 28'th May 2020
Firm's largest sales of the 1st quarter Continue reading...
Why Is IQVIA (IQV) Up 2.6% Since Last Earnings Report?
03:31pm, Thursday, 28'th May 2020
IQVIA (IQV) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Larry Robbins' Firm Chips Away at Top Holdings During the 1st Quarter
11:14pm, Wednesday, 27'th May 2020
Glenview’s sells include Cigna and HCA Continue reading...
Hedge Funds Kept Selling IQVIA Holdings, Inc. (IQV) During The Crash
07:54pm, Tuesday, 26'th May 2020
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data. We at Insider Monkey have plowed through 821 13F
Anti-anxiety medication prescriptions have spiked 34% during the coronavirus pandemic
02:54pm, Tuesday, 26'th May 2020
Americans are also filling more prescriptions for antidepressants and anti-insomnia drugs
More People Are Taking Drugs for Anxiety and Insomnia, and Doctors Are Worried
01:00pm, Monday, 25'th May 2020
As coronavirus health concerns, social isolation and job-loss stress take a toll, people turn to medications; “It can very quickly become a habit.”
IQVIA™ (NYSE: IQV) today announced the launch of HCP/O Engagement Management, the industry’s first end-to-end, orchestrated healthcare professional/organization (HCP/O) solution that enables the p
IQVIA™ (NYSE: IQV) today announced the launch of HCP/O Engagement Management, the industry’s first end-to-end, orchestrated healthcare professional/or
IQVIA Collaborates with Australian Medical Research Institute on COVID-19 Study to Support Frontline Healthcare Workers
12:00pm, Wednesday, 20'th May 2020
IQVIA™ (NYSE: IQV) today announced that the Walter and Eliza Hall Institute of Medical Research, a leading biomedical research organization in Australia, has selected IQVIA to manage COVID SHIELD, a
Trump attacks study, defends using malaria drug for COVID-19
04:13am, Wednesday, 20'th May 2020
President Donald Trump attacked the validity of a study of veterans that raised alarms about the malaria drug he actively promotes as a treatment for the coronavirus
IQVIA Collaborates with Australian Medical Research Institute on COVID-19 Study to Support Frontline Healthcare Workers
12:00am, Wednesday, 20'th May 2020
IQVIA™ (NYSE: IQV) today announced that the Walter and Eliza Hall Institute of Medical Research, a leading biomedical research organization in Austral
Veeva: Strength In An Unsteady Environment (NYSE:VEEV)
10:30pm, Tuesday, 19'th May 2020
Veeva has exceeded expectations due to strong revenue growth in the recent quarter. Competition has been aggressive but Veeva appears to be winning. The company
From Hollywood A-listers to a dragon - the Berkshire Rich List
03:51pm, Tuesday, 19'th May 2020
There is some serious money in the county
AroCell publ : TK1 measurements in serum correlate with the treatment response in breast cancer patients | MarketScreener
09:51am, Tuesday, 19'th May 2020Despite risks, Trump says he's taking hydroxychloroquine
09:42am, Tuesday, 19'th May 2020
President Donald Trump is drawing criticism from Democratic leaders after saying he has been taking the malaria drug he has touted as a treatment for the coronavirus
